Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila

Neuropsychopharmacology

Volumn 30, Issue 12, 2005, Pages 2216-2224

  Dokucu, Mehmet E ^a   Yu, Liangping ^a   Taghert, Paul H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Circadian rhythms; Drosophila; Genetics; Lithium; Pharmacology; Valproate

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; VALPROIC ACID;

ANIMAL BEHAVIOR; ARTICLE; CIRCADIAN RHYTHM; DROSOPHILA; DRUG EFFECT; GENE MUTATION; GENE OVEREXPRESSION; GENETIC MANIPULATION; HETEROZYGOTE; LOCOMOTION; NONHUMAN; PACEMAKER NERVE CELL; PRIORITY JOURNAL;

ANIMALS; ANTIMANIC AGENTS; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; DROSOPHILA; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; MOTOR ACTIVITY; VALPROIC ACID;

EID: 27544515677     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300764     Document Type: Article

References (54)

1. Abe M, Herzog ED, Block GD (2000). Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 11: 3261-3264.
2. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C et al (2004). A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355: 37-40.
3. Bertholf RL, Savory MG, Winborne KH, Hundley JC, Plummer GM, Savory J (1988). Lithium determined in serum with an ion-selective electrode. Clin Chem 34: 1500-1502.
4. Bunney WE, Bunney BG (2000). Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22: 335-345.
5. Chen G, Huang LD, Jiang YM, Manji HK (1999a). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72: 1327-1330.
6. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH et al (1999b). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72: 879-882.
7. DeZazzo J, Tully T (1995). Dissection of memory formation: from behavioral pharmacology to molecular genetics. Trends Neurosci 18: 212-218.
8. Du J, Gray NA, Falke C, Yuan P, Szabo S, Manji HK (2003). Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann NY Acad Sci 1003: 378-380.
9. Duncan WC, Johnson Jr KA, Wehr TA (1998). Decreased sensitivity to light of the photic entrainment pathway during chronic clorgyline and lithium treatments. J Biol Rhythms 13: 330-346.
10. Einat H, Manji HK, Gould TD, Du J, Chen G (2003). Possible involvement of the ERK signaling cascade in bipolar disorder: behavioral leads from the study of mutant mice. Drug News Perspect 16: 453-463.
11. Gonzalez RG, Guimaraes AR, Sachs GS, Rosenbaum JF, Garwood M, Renshaw PF (1993). Measurement of human brain lithium in vivo by MR spectroscopy. AJNR Am J Neuroradiol 14: 1027-1037.
12. Gould TD, Chen G, Manji HK (2004). In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29: 32-38.
13. Gurvich N, Klein PS (2002). Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol Ther 96: 45-66.
14. Harwood AJ. (2003). Neurodevelopment and mood stabilizers. Curr Mol Med 3: 472-482.
15. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS (1997). Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185: 82-91.
16. Hendricks JC, Williams JA, Panckeri K, Kirk D, Tello M, Yin JC et al (2001). A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis. Nat Neurosci 4: 1108-1115.
17. Ikonomov OC, Manji HK (1999). Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. Am J Psychiatry 156: 1506-1514.
18. Iwahana E, kiyama MA, Miyakawa K, Uchida A, Kasahara J, Fukunaga K et al (2004). Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci 19: 2281-2287.
19. Johnsson A, Engelmann W, Pflug B, Klemke W (1980). Influence of lithium ions on human circadian rhythms. Z Naturforsch [C] 35: 503-507.
20. Jope RS (2003). Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24: 441-443.
21. Kato T, Takahashi S, Inubushi T (1992). Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res 45: 53-63.
22. Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459.
23. Klemfuss H. (1992). Rhythms and the pharmacology of lithium. Pharmacol Ther 56: 53-78.
24. Kripke DF, Wyborney VG (1980). Lithium slows rat circadian activity rhythms. Life Sci 26: 1319-1321.
25. Leibenluft E, Frank E (2001). Circadian rhythms in affective disorders. In: Takahashi JS, Turek FW, Moore RY (eds). Circadian Clocks. Kluwer Academic/Plenum Publishers: New York. Vol 12, pp 625-644.
26. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G (1999a). Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 60(Suppl 2): 27-39 discussion 40-41, 113-116.
27. Manji HK, Chen G (2002). PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry 7(Suppl 1): S46-S56.
28. Manji HK, Lenox RH (2000). The nature of bipolar disorder. J Clin Psychiatry 61(Suppl 13): 42-57.
29. Manji HK, Moore GJ, Chen G (1999b). Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46: 929-940.
30. Manji HK, Moore GJ, Chen G (2001). Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry Suppl 41: s107-s119.
31. Martinek S, Inonog S, Manoukian AS, Young MW (2001). A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock. Cell 105: 769-779.
32. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Menji HK (2000). Lithium-induced increase in human brain grey matter. Lancet 356: 1241-1242.
33. Padiath QS, Paranjpe D, Jain S, Sharma VK (2004). Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol Int 21: 43-55.
34. Park JH, Helfrich-Forster C, Lee G, Liu L, Rosbash M, Hall JC (2000). Differential regulation of circadian pacemaker output by separate clock genes in Drosophila. Proc Natl Acad Sci USA 97: 3608-3613.
35. Phiel CJ, Wilson CA, Lee VM, Klein PS (2003). GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423: 435-439.
36. Plenge P, Stensgaard A, Jensen HV, Thomsen C, Mellerup ET, Henriksen O (1994). 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol Psychiatry 36: 511-516.
37. Ryves WJ, Harwood AJ (2001). Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280: 720-725.
38. Seggie J, Carney PA, Parker J, Grof E, Grof P (1989). Effect of chronic lithium on sensitivity to light in male and female bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 13: 543-549.
39. Shaldubina A, Agam G, Belmaker RH (2001). The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry 25: 855-866.
40. Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M et al (2004). Valproate decreases inositol biosynthesis. Biol Psychiatry 56: 868-874.
41. Shaw PJ, Tononi G, Greenspan RJ, Robinson DF (2002). Stress response genes protect against lethal effects of sleep deprivation in Drosophila. Nature 417: 287-291.
42. Simon MA. (1994). Signal transduction during the development of the Drosophila R7 photoreceptor. Dev Biol 166: 431-442.
43. Stambolic V, Ruel L, Woodgett JR (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6: 1664-1668.
44. Taghert PH, Hewes RS, Park JH, O'Brien MA, Han M, Peck ME (2001). Multiple amidated neuropeptides are required for normal circadian locomotor rhythms in Drosophila. J Neurosci 21: 6673-6686.
45. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM et al (2001). An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291: 1040-1043.
46. Wang GK, Sehgal A (2002). Signaling components that drive circadian rhythms. Curr Opin Neurobiol 12: 331-338.
47. Welsh DK, Moore-Ede MC (1990). Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus. Biol Psychiatry 28: 117-126.
48. Williams JA, Sehgal A (2001). Molecular components of the circadian system in Drosophila. Annu Rev Physiol 63: 729-755.
49. Williams RS, Cheng L, Mudge AW, Harwood AJ (2002). A common mechanism of action for three mood-stabilizing drugs. Nature 417: 292-295.
50. Williams RS, Harwood AJ (2000). Lithium therapy and signal transduction. Trends Pharmacol Sci 21: 61-64.
51. Williamson RL. (1982). Lithium stops hereditary shuddering in Drosophila melanogaster. Psychopharmacology (Berl) 76: 265-268.
52. Wolf FW, Heberlein U (2003). Invertebrate models of drug abuse. J Neurobiol 54: 161-178.
53. Wolf ME (1999). Cocaine addiction: clues from Drosophila on drugs. Curr Biol 9: R770-R772.
54. Xia S, Liu L, Feng C, Guo A (1997). Drug disruption of short-term memory in Drosophila melanogaster. Pharmacol Biochem Behav 58: 727-735.